

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.12550456 |
| 2 | DNA deamination (GO:0045006) | 5.77920345 |
| 3 | viral transcription (GO:0019083) | 5.18506741 |
| 4 | translational termination (GO:0006415) | 5.01715836 |
| 5 | maturation of SSU-rRNA (GO:0030490) | 5.00483144 |
| 6 | chaperone-mediated protein transport (GO:0072321) | 4.91188867 |
| 7 | proteasome assembly (GO:0043248) | 4.85777396 |
| 8 | ribosomal small subunit biogenesis (GO:0042274) | 4.77078760 |
| 9 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.77057166 |
| 10 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.76810481 |
| 11 | oxidative phosphorylation (GO:0006119) | 4.73676088 |
| 12 | ribosomal large subunit biogenesis (GO:0042273) | 4.67575762 |
| 13 | respiratory electron transport chain (GO:0022904) | 4.63983112 |
| 14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.57135071 |
| 15 | translational elongation (GO:0006414) | 4.55218700 |
| 16 | electron transport chain (GO:0022900) | 4.52110851 |
| 17 | cotranslational protein targeting to membrane (GO:0006613) | 4.49128220 |
| 18 | protein targeting to ER (GO:0045047) | 4.44452782 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.41517577 |
| 20 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.36303927 |
| 21 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.33340125 |
| 22 | formation of translation preinitiation complex (GO:0001731) | 4.25068010 |
| 23 | protein localization to endoplasmic reticulum (GO:0070972) | 4.21726061 |
| 24 | translational initiation (GO:0006413) | 4.21603331 |
| 25 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.19650550 |
| 26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.16228217 |
| 27 | protein complex biogenesis (GO:0070271) | 4.10514380 |
| 28 | DNA strand elongation (GO:0022616) | 4.09432582 |
| 29 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.03743925 |
| 30 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.03486086 |
| 31 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.02696655 |
| 32 | negative regulation of ligase activity (GO:0051352) | 4.00727985 |
| 33 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.00727985 |
| 34 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.00600837 |
| 35 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.95780726 |
| 36 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.95107711 |
| 37 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.95107711 |
| 38 | protein targeting to mitochondrion (GO:0006626) | 3.94908215 |
| 39 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.92467221 |
| 40 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.92307492 |
| 41 | 7-methylguanosine mRNA capping (GO:0006370) | 3.92127835 |
| 42 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.92111652 |
| 43 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.92111652 |
| 44 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.92111652 |
| 45 | cellular protein complex disassembly (GO:0043624) | 3.92088372 |
| 46 | translation (GO:0006412) | 3.92034273 |
| 47 | telomere maintenance via recombination (GO:0000722) | 3.90768004 |
| 48 | viral life cycle (GO:0019058) | 3.90248380 |
| 49 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.90009929 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.87967455 |
| 51 | rRNA modification (GO:0000154) | 3.86634290 |
| 52 | RNA capping (GO:0036260) | 3.85741748 |
| 53 | 7-methylguanosine RNA capping (GO:0009452) | 3.85741748 |
| 54 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.82972766 |
| 55 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.82972766 |
| 56 | termination of RNA polymerase III transcription (GO:0006386) | 3.79472964 |
| 57 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.79472964 |
| 58 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.79429563 |
| 59 | regulation of mitochondrial translation (GO:0070129) | 3.77030372 |
| 60 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.75909206 |
| 61 | ubiquinone biosynthetic process (GO:0006744) | 3.75715784 |
| 62 | nucleobase biosynthetic process (GO:0046112) | 3.71312290 |
| 63 | establishment of protein localization to mitochondrion (GO:0072655) | 3.70306471 |
| 64 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.70243423 |
| 65 | base-excision repair, AP site formation (GO:0006285) | 3.70189674 |
| 66 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.69830417 |
| 67 | DNA replication initiation (GO:0006270) | 3.69275907 |
| 68 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.67737986 |
| 69 | purine nucleobase biosynthetic process (GO:0009113) | 3.63657311 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.61511503 |
| 71 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.60351387 |
| 72 | ATP synthesis coupled proton transport (GO:0015986) | 3.60351387 |
| 73 | rRNA processing (GO:0006364) | 3.59890098 |
| 74 | pseudouridine synthesis (GO:0001522) | 3.59873626 |
| 75 | spliceosomal snRNP assembly (GO:0000387) | 3.58557540 |
| 76 | protein localization to mitochondrion (GO:0070585) | 3.58305950 |
| 77 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.55182553 |
| 78 | ribosome biogenesis (GO:0042254) | 3.54155498 |
| 79 | NADH metabolic process (GO:0006734) | 3.52943720 |
| 80 | cullin deneddylation (GO:0010388) | 3.52683405 |
| 81 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.52317186 |
| 82 | protein deneddylation (GO:0000338) | 3.51154741 |
| 83 | cellular component biogenesis (GO:0044085) | 3.50329046 |
| 84 | telomere maintenance via telomere lengthening (GO:0010833) | 3.48623038 |
| 85 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.47892136 |
| 86 | rRNA metabolic process (GO:0016072) | 3.46752002 |
| 87 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.46598823 |
| 88 | protein complex disassembly (GO:0043241) | 3.45367460 |
| 89 | mitotic recombination (GO:0006312) | 3.42236604 |
| 90 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.41804640 |
| 91 | ATP biosynthetic process (GO:0006754) | 3.40899065 |
| 92 | metallo-sulfur cluster assembly (GO:0031163) | 3.39992436 |
| 93 | iron-sulfur cluster assembly (GO:0016226) | 3.39992436 |
| 94 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.39866880 |
| 95 | cytochrome complex assembly (GO:0017004) | 3.39042349 |
| 96 | ubiquinone metabolic process (GO:0006743) | 3.36545354 |
| 97 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.35225070 |
| 98 | deoxyribose phosphate catabolic process (GO:0046386) | 3.34108740 |
| 99 | deoxyribonucleotide catabolic process (GO:0009264) | 3.34092858 |
| 100 | termination of RNA polymerase I transcription (GO:0006363) | 3.34028378 |
| 101 | positive regulation of ligase activity (GO:0051351) | 3.33403964 |
| 102 | DNA replication checkpoint (GO:0000076) | 3.32216291 |
| 103 | macromolecular complex disassembly (GO:0032984) | 3.30192440 |
| 104 | mitochondrial transport (GO:0006839) | 3.29992765 |
| 105 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.28968232 |
| 106 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.28811244 |
| 107 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.28183267 |
| 108 | peptidyl-histidine modification (GO:0018202) | 3.26289033 |
| 109 | positive regulation of cell cycle arrest (GO:0071158) | 3.23671161 |
| 110 | quinone biosynthetic process (GO:1901663) | 3.20626695 |
| 111 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.19691328 |
| 112 | establishment of integrated proviral latency (GO:0075713) | 3.17494740 |
| 113 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.16529748 |
| 114 | rRNA methylation (GO:0031167) | 3.16068664 |
| 115 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.15142172 |
| 116 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.15142172 |
| 117 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.14694679 |
| 118 | CENP-A containing nucleosome assembly (GO:0034080) | 3.14511620 |
| 119 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.13200686 |
| 120 | respiratory chain complex IV assembly (GO:0008535) | 3.12599573 |
| 121 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.12402832 |
| 122 | transcription from RNA polymerase I promoter (GO:0006360) | 3.10763908 |
| 123 | GTP biosynthetic process (GO:0006183) | 3.10541094 |
| 124 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.09200527 |
| 125 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.08738018 |
| 126 | cell cycle G1/S phase transition (GO:0044843) | 3.08738018 |
| 127 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.07892689 |
| 128 | tRNA methylation (GO:0030488) | 3.05301104 |
| 129 | L-methionine salvage (GO:0071267) | 3.05182222 |
| 130 | L-methionine biosynthetic process (GO:0071265) | 3.05182222 |
| 131 | amino acid salvage (GO:0043102) | 3.05182222 |
| 132 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.04883659 |
| 133 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.04883659 |
| 134 | regulation of ligase activity (GO:0051340) | 3.03572888 |
| 135 | NADH dehydrogenase complex assembly (GO:0010257) | 3.00709322 |
| 136 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.00709322 |
| 137 | tricarboxylic acid cycle (GO:0006099) | 2.99980615 |
| 138 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.99808515 |
| 139 | protein neddylation (GO:0045116) | 2.99130656 |
| 140 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.98053234 |
| 141 | inner mitochondrial membrane organization (GO:0007007) | 2.93885838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.52497479 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.35325861 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.33064355 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.99434571 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.83607554 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.82396715 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.70723484 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.44987264 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.19519043 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.19027589 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.11589651 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.05571214 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.84985120 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.83504942 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.83301892 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.66962049 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.59604912 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.56486900 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.52327820 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.51446481 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.48214888 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.44670095 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.39382797 |
| 24 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.36556634 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.34623720 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.29278062 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.24204080 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.21434099 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.14874169 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.10390255 |
| 31 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.10058393 |
| 32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.08273218 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03371711 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.00912868 |
| 35 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.90245759 |
| 36 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.88189791 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81111637 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81026130 |
| 39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79116649 |
| 40 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.72295032 |
| 41 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.72236082 |
| 42 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71864999 |
| 43 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.71299313 |
| 44 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.68973579 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66818381 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63690859 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.61865827 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.58858933 |
| 49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.57926703 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.57249152 |
| 51 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.51451084 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51368438 |
| 53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48634922 |
| 54 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47611570 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46730754 |
| 56 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42785254 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39161604 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39013822 |
| 59 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.38116656 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32910288 |
| 61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31142115 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27711548 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.24622871 |
| 64 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.23348643 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22639168 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22320973 |
| 67 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21674000 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21065669 |
| 69 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.19823044 |
| 70 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.17601358 |
| 71 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17046506 |
| 72 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.16456032 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15184474 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12271772 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11998915 |
| 76 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.11825036 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.11223778 |
| 78 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09494399 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09298255 |
| 80 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.09151052 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07932997 |
| 82 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07457080 |
| 83 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.05178220 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03485517 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03245874 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03040007 |
| 87 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01808387 |
| 88 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.98774392 |
| 89 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98610828 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98370096 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97921787 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97597857 |
| 93 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94767970 |
| 94 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94240733 |
| 95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94191182 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93865651 |
| 97 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.92030153 |
| 98 | MYC_22102868_ChIP-Seq_BL_Human | 0.91958697 |
| 99 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91738142 |
| 100 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.91290359 |
| 101 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89774393 |
| 102 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.89765353 |
| 103 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89513211 |
| 104 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88822018 |
| 105 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.88533244 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 0.86787563 |
| 107 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86155351 |
| 108 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.85152207 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85151684 |
| 110 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85140473 |
| 111 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.84040816 |
| 112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83847174 |
| 113 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.82785046 |
| 114 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.80936737 |
| 115 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.79064719 |
| 116 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.77784223 |
| 117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.77212388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.03592657 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.88627663 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.45439342 |
| 4 | MP0003077_abnormal_cell_cycle | 3.42744332 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.42620212 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.39314868 |
| 7 | MP0008058_abnormal_DNA_repair | 3.21592434 |
| 8 | MP0006292_abnormal_olfactory_placode | 2.99374872 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 2.95923869 |
| 10 | MP0008057_abnormal_DNA_replication | 2.75695155 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.69304701 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.62922767 |
| 13 | MP0000749_muscle_degeneration | 2.55752045 |
| 14 | MP0002132_abnormal_respiratory_system | 2.54694060 |
| 15 | MP0008932_abnormal_embryonic_tissue | 2.41763438 |
| 16 | MP0003786_premature_aging | 2.40391171 |
| 17 | MP0003718_maternal_effect | 2.29869564 |
| 18 | MP0005451_abnormal_body_composition | 2.27279980 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 2.19440312 |
| 20 | MP0003186_abnormal_redox_activity | 2.15574269 |
| 21 | MP0000751_myopathy | 2.12232862 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 2.02080966 |
| 23 | MP0005360_urolithiasis | 1.99443812 |
| 24 | MP0008260_abnormal_autophagy | 1.94768627 |
| 25 | MP0002822_catalepsy | 1.92451035 |
| 26 | MP0001661_extended_life_span | 1.91438737 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.86229048 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.84916324 |
| 29 | MP0005330_cardiomyopathy | 1.70927831 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.64447442 |
| 31 | MP0005671_abnormal_response_to | 1.63696970 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.63336200 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.60475849 |
| 34 | MP0004233_abnormal_muscle_weight | 1.56918279 |
| 35 | MP0004147_increased_porphyrin_level | 1.55658844 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.55483898 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.54256938 |
| 38 | MP0005332_abnormal_amino_acid | 1.54247112 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.54231068 |
| 40 | MP0002102_abnormal_ear_morphology | 1.50172543 |
| 41 | MP0002938_white_spotting | 1.49493794 |
| 42 | MP0003011_delayed_dark_adaptation | 1.45559975 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.45034486 |
| 44 | MP0000490_abnormal_crypts_of | 1.44701280 |
| 45 | MP0001730_embryonic_growth_arrest | 1.43384384 |
| 46 | MP0002234_abnormal_pharynx_morphology | 1.42774057 |
| 47 | MP0001529_abnormal_vocalization | 1.40779722 |
| 48 | MP0002106_abnormal_muscle_physiology | 1.40432000 |
| 49 | MP0000350_abnormal_cell_proliferation | 1.39858377 |
| 50 | MP0004133_heterotaxia | 1.39416195 |
| 51 | MP0001764_abnormal_homeostasis | 1.38288038 |
| 52 | MP0001853_heart_inflammation | 1.37516629 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.36406281 |
| 54 | MP0000313_abnormal_cell_death | 1.35072306 |
| 55 | MP0009697_abnormal_copulation | 1.33252813 |
| 56 | MP0001727_abnormal_embryo_implantation | 1.32968879 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.31623242 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.29251415 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.29150617 |
| 60 | MP0000358_abnormal_cell_content/ | 1.27289169 |
| 61 | MP0002398_abnormal_bone_marrow | 1.26186914 |
| 62 | MP0009785_altered_susceptibility_to | 1.24910123 |
| 63 | MP0000759_abnormal_skeletal_muscle | 1.23167739 |
| 64 | MP0000747_muscle_weakness | 1.22569304 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.21839666 |
| 66 | MP0002722_abnormal_immune_system | 1.20952780 |
| 67 | MP0005085_abnormal_gallbladder_physiolo | 1.14807339 |
| 68 | MP0000566_synostosis | 1.14492468 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.13636331 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.13636331 |
| 71 | MP0005365_abnormal_bile_salt | 1.11865296 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.11031405 |
| 73 | MP0010030_abnormal_orbit_morphology | 1.09768368 |
| 74 | MP0002095_abnormal_skin_pigmentation | 1.09708999 |
| 75 | MP0002429_abnormal_blood_cell | 1.09285919 |
| 76 | MP0003136_yellow_coat_color | 1.07871726 |
| 77 | MP0003315_abnormal_perineum_morphology | 1.07139082 |
| 78 | MP0002080_prenatal_lethality | 1.07065113 |
| 79 | MP0001293_anophthalmia | 1.05204301 |
| 80 | MP0002249_abnormal_larynx_morphology | 1.04775007 |
| 81 | MP0005670_abnormal_white_adipose | 1.04706333 |
| 82 | MP0005174_abnormal_tail_pigmentation | 1.01566610 |
| 83 | MP0003123_paternal_imprinting | 1.01492561 |
| 84 | MP0000015_abnormal_ear_pigmentation | 1.01241014 |
| 85 | MP0000858_altered_metastatic_potential | 1.00452401 |
| 86 | MP0000703_abnormal_thymus_morphology | 1.00165401 |
| 87 | MP0005266_abnormal_metabolism | 1.00036860 |
| 88 | MP0005369_muscle_phenotype | 0.99645023 |
| 89 | MP0003646_muscle_fatigue | 0.99588776 |
| 90 | MP0002163_abnormal_gland_morphology | 0.99531582 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99528334 |
| 92 | MP0000716_abnormal_immune_system | 0.98036589 |
| 93 | MP0001697_abnormal_embryo_size | 0.97514625 |
| 94 | MP0002210_abnormal_sex_determination | 0.97392011 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.96442230 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.95341540 |
| 97 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95136194 |
| 98 | MP0000685_abnormal_immune_system | 0.94945305 |
| 99 | MP0009840_abnormal_foam_cell | 0.92541477 |
| 100 | MP0005025_abnormal_response_to | 0.92435122 |
| 101 | MP0004087_abnormal_muscle_fiber | 0.90436695 |
| 102 | MP0002269_muscular_atrophy | 0.90358724 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.89618374 |
| 104 | MP0002420_abnormal_adaptive_immunity | 0.87763451 |
| 105 | MP0000049_abnormal_middle_ear | 0.87628392 |
| 106 | MP0001800_abnormal_humoral_immune | 0.86705521 |
| 107 | MP0001145_abnormal_male_reproductive | 0.86675613 |
| 108 | MP0001819_abnormal_immune_cell | 0.86353109 |
| 109 | MP0001905_abnormal_dopamine_level | 0.85638119 |
| 110 | MP0003724_increased_susceptibility_to | 0.81938487 |
| 111 | MP0002736_abnormal_nociception_after | 0.81145523 |
| 112 | MP0005394_taste/olfaction_phenotype | 0.80918052 |
| 113 | MP0005499_abnormal_olfactory_system | 0.80918052 |
| 114 | MP0004142_abnormal_muscle_tone | 0.80359774 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.78959709 |
| 116 | MP0003137_abnormal_impulse_conducting | 0.78845778 |
| 117 | MP0002405_respiratory_system_inflammati | 0.78665904 |
| 118 | MP0002160_abnormal_reproductive_system | 0.78625178 |
| 119 | MP0001188_hyperpigmentation | 0.78393038 |
| 120 | MP0002723_abnormal_immune_serum | 0.78085081 |
| 121 | MP0002148_abnormal_hypersensitivity_rea | 0.77936903 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.77188740 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.76335346 |
| 124 | MP0005380_embryogenesis_phenotype | 0.73514641 |
| 125 | MP0001672_abnormal_embryogenesis/_devel | 0.73514641 |
| 126 | MP0001929_abnormal_gametogenesis | 0.72951390 |
| 127 | MP0005389_reproductive_system_phenotype | 0.72784759 |
| 128 | MP0000372_irregular_coat_pigmentation | 0.72207511 |
| 129 | MP0000750_abnormal_muscle_regeneration | 0.72161826 |
| 130 | MP0005367_renal/urinary_system_phenotyp | 0.70625569 |
| 131 | MP0000516_abnormal_urinary_system | 0.70625569 |
| 132 | MP0000653_abnormal_sex_gland | 0.70508508 |
| 133 | MP0008789_abnormal_olfactory_epithelium | 0.70214984 |
| 134 | MP0002085_abnormal_embryonic_tissue | 0.69609936 |
| 135 | MP0001119_abnormal_female_reproductive | 0.69085835 |
| 136 | MP0002138_abnormal_hepatobiliary_system | 0.68514063 |
| 137 | MP0005000_abnormal_immune_tolerance | 0.68273960 |
| 138 | MP0008469_abnormal_protein_level | 0.68093772 |
| 139 | MP0004185_abnormal_adipocyte_glucose | 0.66883667 |
| 140 | MP0000678_abnormal_parathyroid_gland | 0.66215393 |
| 141 | MP0005636_abnormal_mineral_homeostasis | 0.66101121 |
| 142 | MP0009643_abnormal_urine_homeostasis | 0.62129641 |
| 143 | MP0005376_homeostasis/metabolism_phenot | 0.61473169 |
| 144 | MP0003984_embryonic_growth_retardation | 0.60323086 |
| 145 | MP0002972_abnormal_cardiac_muscle | 0.59503486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.74518554 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.35160528 |
| 3 | Reticulocytopenia (HP:0001896) | 4.48428401 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.35158762 |
| 5 | Hepatocellular necrosis (HP:0001404) | 4.27688635 |
| 6 | Mitochondrial inheritance (HP:0001427) | 4.26585652 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.08499278 |
| 8 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.99224194 |
| 9 | Nemaline bodies (HP:0003798) | 3.97742252 |
| 10 | Muscle fiber inclusion bodies (HP:0100299) | 3.96607451 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.95978310 |
| 12 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.95978310 |
| 13 | Hepatic necrosis (HP:0002605) | 3.87112909 |
| 14 | Increased CSF lactate (HP:0002490) | 3.84739900 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.84475677 |
| 16 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.81869109 |
| 17 | Birth length less than 3rd percentile (HP:0003561) | 3.77355787 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.65093401 |
| 19 | Acute encephalopathy (HP:0006846) | 3.64178402 |
| 20 | Macrocytic anemia (HP:0001972) | 3.60590077 |
| 21 | Aplastic anemia (HP:0001915) | 3.51026966 |
| 22 | Lipid accumulation in hepatocytes (HP:0006561) | 3.45203893 |
| 23 | Progressive macrocephaly (HP:0004481) | 3.41081214 |
| 24 | Increased serum lactate (HP:0002151) | 3.38919595 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.32868262 |
| 26 | Type I transferrin isoform profile (HP:0003642) | 3.31655995 |
| 27 | Rhabdomyolysis (HP:0003201) | 3.30704105 |
| 28 | Pallor (HP:0000980) | 3.27568428 |
| 29 | Oral leukoplakia (HP:0002745) | 3.23866241 |
| 30 | Exercise intolerance (HP:0003546) | 3.09997385 |
| 31 | 3-Methylglutaconic aciduria (HP:0003535) | 3.06645366 |
| 32 | Cerebral hypomyelination (HP:0006808) | 3.06360173 |
| 33 | Increased intramyocellular lipid droplets (HP:0012240) | 3.06044507 |
| 34 | Lactic acidosis (HP:0003128) | 3.00301759 |
| 35 | Microretrognathia (HP:0000308) | 2.96188553 |
| 36 | Exercise-induced muscle cramps (HP:0003710) | 2.94573237 |
| 37 | Ragged-red muscle fibers (HP:0003200) | 2.94383763 |
| 38 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.93135071 |
| 39 | Exertional dyspnea (HP:0002875) | 2.84071455 |
| 40 | Myopathic facies (HP:0002058) | 2.82205079 |
| 41 | Microvesicular hepatic steatosis (HP:0001414) | 2.82035232 |
| 42 | Increased serum pyruvate (HP:0003542) | 2.79798513 |
| 43 | Abnormality of glycolysis (HP:0004366) | 2.79798513 |
| 44 | Cerebral edema (HP:0002181) | 2.78464091 |
| 45 | Breast hypoplasia (HP:0003187) | 2.73732150 |
| 46 | Exercise-induced myalgia (HP:0003738) | 2.61835522 |
| 47 | Increased muscle lipid content (HP:0009058) | 2.58906016 |
| 48 | Respiratory difficulties (HP:0002880) | 2.58866799 |
| 49 | Myoglobinuria (HP:0002913) | 2.55136577 |
| 50 | Pancytopenia (HP:0001876) | 2.50234450 |
| 51 | Progressive muscle weakness (HP:0003323) | 2.49645561 |
| 52 | Respiratory failure (HP:0002878) | 2.46826203 |
| 53 | Absent thumb (HP:0009777) | 2.45408050 |
| 54 | Abnormal protein glycosylation (HP:0012346) | 2.41500808 |
| 55 | Abnormal glycosylation (HP:0012345) | 2.41500808 |
| 56 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.41500808 |
| 57 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.41500808 |
| 58 | Generalized aminoaciduria (HP:0002909) | 2.40723707 |
| 59 | Type 2 muscle fiber atrophy (HP:0003554) | 2.38514586 |
| 60 | Rimmed vacuoles (HP:0003805) | 2.36713661 |
| 61 | Muscle fiber atrophy (HP:0100295) | 2.34976138 |
| 62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33799097 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 2.33799097 |
| 64 | Abnormality of the anterior horn cell (HP:0006802) | 2.33195546 |
| 65 | Degeneration of anterior horn cells (HP:0002398) | 2.33195546 |
| 66 | Poor head control (HP:0002421) | 2.33154015 |
| 67 | Reduced antithrombin III activity (HP:0001976) | 2.31813367 |
| 68 | CNS demyelination (HP:0007305) | 2.28719484 |
| 69 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.28128467 |
| 70 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.27420817 |
| 71 | Rough bone trabeculation (HP:0100670) | 2.26880940 |
| 72 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.25421707 |
| 73 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.23416532 |
| 74 | Abnormality of DNA repair (HP:0003254) | 2.22180102 |
| 75 | Patellar aplasia (HP:0006443) | 2.14549957 |
| 76 | Amniotic constriction ring (HP:0009775) | 2.14547438 |
| 77 | Abnormality of placental membranes (HP:0011409) | 2.14547438 |
| 78 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.10308204 |
| 79 | Trismus (HP:0000211) | 2.09948567 |
| 80 | IgM deficiency (HP:0002850) | 2.08676684 |
| 81 | Premature graying of hair (HP:0002216) | 2.08282390 |
| 82 | Thyroid-stimulating hormone excess (HP:0002925) | 2.07825949 |
| 83 | Muscle stiffness (HP:0003552) | 2.07684112 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06652102 |
| 85 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.04119974 |
| 86 | Abnormal number of incisors (HP:0011064) | 2.02924443 |
| 87 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.02635469 |
| 88 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.02574874 |
| 89 | Poikiloderma (HP:0001029) | 2.01712678 |
| 90 | Emotional lability (HP:0000712) | 2.01333532 |
| 91 | Selective tooth agenesis (HP:0001592) | 2.00319694 |
| 92 | Hyperphosphaturia (HP:0003109) | 1.99499081 |
| 93 | Distal arthrogryposis (HP:0005684) | 1.99164470 |
| 94 | Abnormal pupillary function (HP:0007686) | 1.96929521 |
| 95 | Sparse eyelashes (HP:0000653) | 1.95381470 |
| 96 | Colon cancer (HP:0003003) | 1.94875137 |
| 97 | Chromsome breakage (HP:0040012) | 1.94264456 |
| 98 | Hyperglycinemia (HP:0002154) | 1.91849767 |
| 99 | Lethargy (HP:0001254) | 1.89824393 |
| 100 | Testicular atrophy (HP:0000029) | 1.89229900 |
| 101 | Cleft eyelid (HP:0000625) | 1.88956503 |
| 102 | Type 1 muscle fiber predominance (HP:0003803) | 1.88908642 |
| 103 | Abnormality of renal resorption (HP:0011038) | 1.88109147 |
| 104 | Hypoplastic heart (HP:0001961) | 1.86910387 |
| 105 | Abnormality of the preputium (HP:0100587) | 1.86426533 |
| 106 | Cellular immunodeficiency (HP:0005374) | 1.85369905 |
| 107 | Leukodystrophy (HP:0002415) | 1.84994882 |
| 108 | Triphalangeal thumb (HP:0001199) | 1.84950291 |
| 109 | Methylmalonic aciduria (HP:0012120) | 1.84894906 |
| 110 | Carpal bone hypoplasia (HP:0001498) | 1.84722479 |
| 111 | Optic disc pallor (HP:0000543) | 1.84578475 |
| 112 | Secondary amenorrhea (HP:0000869) | 1.82848328 |
| 113 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.81817343 |
| 114 | Abnormality of glycine metabolism (HP:0010895) | 1.81817343 |
| 115 | Agnosia (HP:0010524) | 1.81337553 |
| 116 | Bone marrow hypocellularity (HP:0005528) | 1.81170617 |
| 117 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.80657977 |
| 118 | CNS hypomyelination (HP:0003429) | 1.79255291 |
| 119 | Metabolic acidosis (HP:0001942) | 1.79161634 |
| 120 | Meckel diverticulum (HP:0002245) | 1.78829480 |
| 121 | Thrombocytosis (HP:0001894) | 1.78195866 |
| 122 | Abnormality of reticulocytes (HP:0004312) | 1.77939067 |
| 123 | X-linked dominant inheritance (HP:0001423) | 1.77601248 |
| 124 | Gliosis (HP:0002171) | 1.76937255 |
| 125 | Delayed CNS myelination (HP:0002188) | 1.76920656 |
| 126 | Hyperglycinuria (HP:0003108) | 1.75190727 |
| 127 | Hypoplastic left heart (HP:0004383) | 1.74001340 |
| 128 | Prolonged neonatal jaundice (HP:0006579) | 1.73775542 |
| 129 | Gout (HP:0001997) | 1.73119134 |
| 130 | Nausea (HP:0002018) | 1.71690295 |
| 131 | Vomiting (HP:0002013) | 1.71587243 |
| 132 | Dry hair (HP:0011359) | 1.71585152 |
| 133 | Calf muscle hypertrophy (HP:0008981) | 1.71421056 |
| 134 | Abnormality of urine glucose concentration (HP:0011016) | 1.71006814 |
| 135 | Glycosuria (HP:0003076) | 1.71006814 |
| 136 | Abnormality of the ileum (HP:0001549) | 1.70308217 |
| 137 | Premature ovarian failure (HP:0008209) | 1.69466483 |
| 138 | 11 pairs of ribs (HP:0000878) | 1.69144370 |
| 139 | Hypoplasia of the radius (HP:0002984) | 1.68163938 |
| 140 | Postnatal microcephaly (HP:0005484) | 1.67713986 |
| 141 | Hypoplasia of the uterus (HP:0000013) | 1.67183951 |
| 142 | Hyperammonemia (HP:0001987) | 1.64293576 |
| 143 | Paralysis (HP:0003470) | 1.62265983 |
| 144 | EMG: myopathic abnormalities (HP:0003458) | 1.61508817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.67655612 |
| 2 | BUB1 | 5.32363649 |
| 3 | EIF2AK1 | 4.07331720 |
| 4 | NME2 | 3.74832732 |
| 5 | WEE1 | 3.65095466 |
| 6 | STK16 | 3.36447963 |
| 7 | ACVR1B | 2.39154973 |
| 8 | EIF2AK3 | 2.36907121 |
| 9 | VRK1 | 2.21662616 |
| 10 | TSSK6 | 2.18313110 |
| 11 | PIM2 | 2.11637137 |
| 12 | TLK1 | 2.11635359 |
| 13 | SRPK1 | 2.02438518 |
| 14 | BCKDK | 1.99311317 |
| 15 | KDR | 1.98779382 |
| 16 | BRAF | 1.98589996 |
| 17 | TAF1 | 1.98416846 |
| 18 | CDC7 | 1.98366109 |
| 19 | TESK2 | 1.97140104 |
| 20 | SMG1 | 1.90931919 |
| 21 | DYRK3 | 1.79370443 |
| 22 | NME1 | 1.78926105 |
| 23 | PDK2 | 1.60630811 |
| 24 | PLK4 | 1.54488222 |
| 25 | PHKG2 | 1.48074570 |
| 26 | PHKG1 | 1.48074570 |
| 27 | CSNK1G3 | 1.38083510 |
| 28 | BRSK2 | 1.35323792 |
| 29 | MUSK | 1.33781417 |
| 30 | NEK2 | 1.32211806 |
| 31 | MAP4K1 | 1.30676806 |
| 32 | CDK7 | 1.30440434 |
| 33 | PLK1 | 1.30134464 |
| 34 | MAP3K11 | 1.28318945 |
| 35 | AURKA | 1.23089469 |
| 36 | ARAF | 1.21358105 |
| 37 | RPS6KB2 | 1.17083359 |
| 38 | BRSK1 | 1.17007999 |
| 39 | NUAK1 | 1.15899102 |
| 40 | CDK8 | 1.14920620 |
| 41 | TTK | 1.14593294 |
| 42 | DAPK1 | 1.12692749 |
| 43 | YES1 | 1.09844257 |
| 44 | IRAK4 | 1.09720539 |
| 45 | DYRK2 | 1.09107309 |
| 46 | ABL2 | 1.08746895 |
| 47 | AURKB | 1.08486158 |
| 48 | CSNK1G1 | 1.03787910 |
| 49 | PBK | 1.00710115 |
| 50 | CSNK1A1L | 0.97411495 |
| 51 | RPS6KA4 | 0.96391478 |
| 52 | ZAK | 0.94907129 |
| 53 | PASK | 0.94322243 |
| 54 | PAK4 | 0.93980736 |
| 55 | DAPK3 | 0.93275940 |
| 56 | ATR | 0.93122397 |
| 57 | NEK1 | 0.92903665 |
| 58 | KIT | 0.92240881 |
| 59 | LRRK2 | 0.90986781 |
| 60 | CSNK1G2 | 0.90723305 |
| 61 | TESK1 | 0.88962329 |
| 62 | MAP4K2 | 0.87364011 |
| 63 | PLK3 | 0.85700956 |
| 64 | BLK | 0.84305466 |
| 65 | MAP2K3 | 0.81625595 |
| 66 | TTN | 0.81305301 |
| 67 | PINK1 | 0.80165882 |
| 68 | MKNK1 | 0.80035493 |
| 69 | ADRBK2 | 0.79468810 |
| 70 | CSNK2A1 | 0.79059478 |
| 71 | CHEK2 | 0.77500111 |
| 72 | MST4 | 0.76793621 |
| 73 | CCNB1 | 0.75144863 |
| 74 | IRAK3 | 0.73774973 |
| 75 | NLK | 0.73240691 |
| 76 | ILK | 0.73225698 |
| 77 | TGFBR1 | 0.72466876 |
| 78 | MAP3K8 | 0.72260738 |
| 79 | CDK19 | 0.71788041 |
| 80 | PAK1 | 0.71323331 |
| 81 | CSNK2A2 | 0.71190475 |
| 82 | MAPKAPK3 | 0.70676386 |
| 83 | PRKD3 | 0.70600461 |
| 84 | EPHA2 | 0.68482958 |
| 85 | CDK4 | 0.67479881 |
| 86 | MKNK2 | 0.66782526 |
| 87 | ZAP70 | 0.66709005 |
| 88 | LIMK1 | 0.66693757 |
| 89 | GRK6 | 0.65895558 |
| 90 | EIF2AK2 | 0.64474066 |
| 91 | PIK3CG | 0.64439469 |
| 92 | MYLK | 0.64191509 |
| 93 | FLT3 | 0.64108911 |
| 94 | STK4 | 0.63924269 |
| 95 | TNIK | 0.62724663 |
| 96 | TXK | 0.61841000 |
| 97 | STK24 | 0.59574243 |
| 98 | PIM1 | 0.59183963 |
| 99 | BTK | 0.56259178 |
| 100 | RPS6KA5 | 0.56161581 |
| 101 | TBK1 | 0.56079518 |
| 102 | OBSCN | 0.55172693 |
| 103 | TYK2 | 0.54355880 |
| 104 | CASK | 0.53233221 |
| 105 | CHEK1 | 0.51110649 |
| 106 | DYRK1B | 0.48756726 |
| 107 | LYN | 0.47268738 |
| 108 | PRKCI | 0.46992796 |
| 109 | CAMK2G | 0.44913659 |
| 110 | CLK1 | 0.44747567 |
| 111 | MAP3K12 | 0.41992140 |
| 112 | BMPR1B | 0.41513485 |
| 113 | CSF1R | 0.39554571 |
| 114 | RAF1 | 0.39357967 |
| 115 | AKT2 | 0.38462550 |
| 116 | TNK2 | 0.38165028 |
| 117 | TAOK2 | 0.36346122 |
| 118 | MAP2K7 | 0.35444991 |
| 119 | MAPK11 | 0.34847578 |
| 120 | TEC | 0.34091348 |
| 121 | IKBKB | 0.32975841 |
| 122 | IRAK2 | 0.32007774 |
| 123 | SYK | 0.31609331 |
| 124 | CDK2 | 0.29494649 |
| 125 | MATK | 0.29357626 |
| 126 | LCK | 0.28948438 |
| 127 | CDK11A | 0.28019862 |
| 128 | EPHB1 | 0.24511659 |
| 129 | CDK14 | 0.23123284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.81162226 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.77790300 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.20057218 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.72705276 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.66210834 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.90680913 |
| 7 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.76310744 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.76142903 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.74587948 |
| 10 | * Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.74424284 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.58551172 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.48421654 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.21667312 |
| 14 | * RNA transport_Homo sapiens_hsa03013 | 2.13078301 |
| 15 | Protein export_Homo sapiens_hsa03060 | 2.08982978 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.85158459 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.72271778 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.68423854 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.67255086 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.62137411 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.59385297 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57695973 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51665084 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.51129545 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.50850824 |
| 26 | Cell cycle_Homo sapiens_hsa04110 | 1.48145738 |
| 27 | Purine metabolism_Homo sapiens_hsa00230 | 1.46063413 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30709645 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.29260002 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.28846126 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22476452 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19787320 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18424408 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18223223 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14531707 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12574323 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05476648 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03579606 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02789504 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01852409 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91618104 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.88201206 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87624022 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84696148 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84080392 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83870678 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82682136 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82313455 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80612429 |
| 50 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.77663115 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74839564 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74660470 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73719719 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70719752 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70246438 |
| 56 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69119974 |
| 57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68106964 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68085704 |
| 59 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.67063079 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66334524 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65931731 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65895458 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63737169 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61046507 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58877831 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58717618 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54244508 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53800827 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51797911 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51628017 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50175022 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49767011 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49673976 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.48188377 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46912854 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46888945 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46876129 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45293164 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42354736 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42255335 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41395071 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41272161 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39189216 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38770253 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.36707981 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.36281590 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34002918 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.31908733 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.28819579 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.28232323 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27782448 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.26561804 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26330211 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26078005 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24439312 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24331090 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.21236151 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21157997 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19992838 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.19794390 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18864762 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.18166531 |
| 103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17453570 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.16365159 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.15884811 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15766129 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.15228316 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.14871076 |
| 109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.14073241 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13501423 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.13231144 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.12982861 |
| 113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.12719469 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12215080 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12055386 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.11532866 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.11445963 |
| 118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10963839 |
| 119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.10779840 |
| 120 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.09900426 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.09179036 |
| 122 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.09014072 |
| 123 | Alcoholism_Homo sapiens_hsa05034 | 0.08509753 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08393706 |

